Endocarditis is a life-threatening disease that is characterized by inflammation of the lining of the heart, primarily caused by bacterial and fungal infections. The firmness of bacterial biofilms on the valves of the heart significantly increases the treatment problems, as biofilms show resistance to antibiotics and immune responses that lead to chronic infections. This condition is further deteriorated by factors such as prosthetic heart valves, the use of drugs intravenously, and underlying cardiac diseases. Effective treatment plans and strategies are required to reduce the incidence of endocarditis. These steps include maintaining good oral hygiene, keeping a check on pre-existing heart conditions, reducing the use of intravenous drugs, and implementing the use of new antibiotics. Despite new advancements in medical treatment, classical antibiotics fail to fully eradicate biofilm-associated endocarditis infections. This necessitates the use of innovative therapeutic approaches. Newer research studies are focusing on herbal medicines that have anti-biofilm properties and offer promising alternatives for disrupting bacterial adhesion and biofilm formation. Additionally, nanotechnology-based approaches, which include nanomedicine use and nano-formulations, are revolutionizing drug delivery, overcoming antibiotic resistance, and improving the penetration into biofilms. These innovations hold great potential for enhancing treatment efficacy, reducing recurrence, and improving patient outcomes. Future research should emphasize early detection, targeted antimicrobial therapies, and biofilm-disrupting agents. As bacterial biofilms are a significant challenge in endocarditis management, collaborative use of nanotechnology and plant-based medicines is required to pave the way for more effective and patient-friendly therapeutic solutions for endocarditis.